SALT LAKE CITY, May 24, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the addition of Folate Receptor Alpha ...

Elahere targets cancer cells with high folate receptor alpha levels, delivering a potent cancer-killing drug. The safety profile of Elahere was favorable, with lower rates of severe side effects and ...

Luveltamab targets the cell surface protein folate receptor alpha, which is important in folate metabolism and, more importantly, has been demonstrated to be a viable target in cancer. AbbVie's ...

Role of Folate Receptor Alpha Testing Mirvetuximab soravtansine, an antibody-drug conjugate targeting FRα, represents the newest approved therapy in ovarian cancer. Testing considerations include ...

"These results position mirvetuximab to become a practice-changing, biomarker-driven, standard of care treatment option for patients with folate receptor, alpha–positive, platinum-resistant ...

PRO1184 PRO1184 is an ADC comprising a folate receptor alpha-directed antibody conjugated to the exatecan payload with ProfoundBio's novel, proprietary hydrophilic linker. The Phase 1 study will ...

The drug, leucovorin, is a prescription vitamin that functions similarly to folic acid ... receptor alpha in the brain." Leucovorin is converted to folate in the brain by a different pathway ...

These negative outcomes may stem from disruptions in the one-carbon (1C) metabolic pathway, including impaired folic acid receptor function ... and tumor necrosis factor-alpha (TNF-α).

today announced the addition of Folate Receptor Alpha (FRα) to its Precise™ Oncology Solutions portfolio. The new biomarker adds another companion diagnostic option for providers to help guide ...